Simon Quick Advisors’s Medicines Co MDCO Stock Holding History

Simon Quick Advisors’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,000	Closed	-$33K	–	448
2017 Q4	$33K	Buy	+1,000	New	+$30.8K	0.01%	271

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Simon Quick Advisors's MDCO Position: Q1 2018 in Review

Simon Quick Advisors sold out of Medicines Co (MDCO) in Q1 2018, closing a stake of 1,000 shares — an estimated $33K sold.

Simon Quick Advisors first reported a position in MDCO in Q4 2017 and held it in 1 quarter. The position peaked at $33K in Q4 2017. 190 funds tracked by Wall St. Rank hold MDCO as of Q1 2018.

Simon Quick Advisors reported no remaining Medicines Co position as of Q1 2018 after selling out during the quarter.
Simon Quick Advisors sold 1,000 Medicines Co shares in Q1 2018, an estimated $33K.
Simon Quick Advisors first reported a position in Medicines Co in Q4 2017 and held it in 1 quarter.
Simon Quick Advisors's Medicines Co position peaked at $33K in Q4 2017.
190 funds tracked by Wall St. Rank held Medicines Co as of Q1 2018.

Based on Simon Quick Advisors's 13F filing for Q1 2018, filed 7 May 2018.